DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has completed its previously announced majority share acquisition of CareCentrix, Inc.—the leading independent home-centered platform that coordinates care to the home for health plans, patients and providers. The majority investment in CareCentrix accelerates Walgreens Health’s capabilities in delivering quality healthcare across a spectrum of settings including primary care, specialty pharmacy ca
Related Posts
Private Equity Titans HIG & CapVest Vie for UK’s Largest Pharma Wholesaler AAH
Bidding War: Private equity giants HIG and CapVest have entered a high-stakes bidding war for AAH Pharmaceuticals, the UK's largest pharmacy wholesaler. Company Profile: AAH services 14,000...
Aspire Biopharma’s $316M SPAC Deal Boosts Biopharma Innovation
Strategic Financing: Aspire Biopharma's $316 million SPAC deal with PowerUp Acquisition Corp. exemplifies the growing trend of biotech firms leveraging SPACs for rapid capital infusion and growth...
EU Court Greenlights Illumina-Grail Merger: Industry Implications
Landmark Ruling: The European Court of Justice (ECJ) nullified the EU's probe into Illumina's $8 billion acquisition of Grail, a cancer diagnostics firm, ruling that the European Commission lacked...
$375M SPAC Merger Boosts Cancer Detection Innovator, CubeBio
Strategic Significance: CubeBio's $375M SPAC merger with Mountain Crest Acquisition Corp. V highlights the growing investor interest in innovative cancer detection technologies. Precision Oncology:...